MBAL:CA:TSX-Mackenzie Balanced Allocation ETF (CAD)

ETF | Others |

Last Closing

CAD 24.17

Change

-1.35 (-5.29)%

Market Cap

CAD 0.12B

Volume

222.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-1.63 (-5.06%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-2.00 (-7.16%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.66 (-2.75%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-2.03 (-5.97%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.97 (-2.08%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-1.04 (-3.77%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.73 (-6.70%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.20 (+0.85%)

CAD 2.78B

ETFs Containing MBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.58% 49% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.58% 49% F 46% F
Trailing 12 Months  
Capital Gain 3.82% 66% D+ 58% F
Dividend Return 2.08% 54% F 36% F
Total Return 5.90% 66% D+ 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.19% 48% F 44% F
Dividend Return 3.65% 46% F 38% F
Total Return 0.46% 57% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 9.47% 54% F 75% C
Risk Adjusted Return 38.54% 41% F 48% F
Market Capitalization 0.12B 66% D+ 37% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.